Evaluation of MRI in Detecting Subclinical Intracranial Metastases from Pulmonary Cancer

汤光宇,徐彧,吴访宏,姚冀平,沈永菊,顾伟中

DOI: https://doi.org/10.3969/j.issn.1001-9324.2002.07.007

2002-01-01

Abstract:Objective To assess the clinical application of MRI in diagnosing subclinical intracranial metastases from primary lung cancer.Materials and Methods Both plain and enhanced cranial MRI was performed in 45 patients with primary lung cancer who showed no craniocerebral symptoms clinically. The incidence of brain metastases was estimated, and the MRI features of the metastases were analyzed. Using Logistic stepwise regression analysis, the correlation of intracranial metastatic occurrence with the possible risk factors was statistically analyzed. The possible risk factors included age, sex, TNM stage, type (central or peripheral), surgically removed or not, the length of the interval period (from the establishment of the diagnosis to discovery of intracranial metastases).Results The incidence of subclinical intracranial metastases was about 31% (14/45). On MRI, the lesions usually displayed as solitary or multiple small nodules, distributed mainly in the peripheral zone with ring-like enhancement. Piamatral and arachnoid metastases were commonly accompanied. The occurrence of intracranial metastases was mainly related to the N stage and the length of the interval period.Conclusion In order to detect subclinical intracranial metastases as early as possible, cranial MRI is strongly recommended for asymptomatic patients who had lung cancer of N 2 or higher stage, or had a long course after the establishment of the diagnosis, even if no symptoms or signs of central nervous system are present clinically.